Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group

In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of prognosis. Some recurrent cytogenetic abnormalities, such as t(8;16)(p11;p13), are so rare that collaborative studies are required to define their prognostic impact. We collected the clinical characteristic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Coenen, Eva A., Zwaan, C. Michel, Reinhardt, Dirk, Harrison, Christine J., Haas, Oskar A., de Haas, Valerie, Mihál, Vladimir, De Moerloose, Barbara, Jeison, Marta, Rubnitz, Jeffrey E., Tomizawa, Daisuke, Johnston, Donna, Alonzo, Todd A., Hasle, Henrik, Auvrignon, Anne, Dworzak, Michael, Pession, Andrea, van der Velden, Vincent H. J., Swansbury, John, Wong, Kit-fai, Terui, Kiminori, Savasan, Sureyya, Winstanley, Mark, Vaitkeviciene, Goda, Zimmermann, Martin, Pieters, Rob, van den Heuvel-Eibrink, Marry M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2013
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314534/
https://ncbi.nlm.nih.gov/pubmed/23974201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-02-485524
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados